HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule.

@article{Wllberg2012HER2positiveTI,
  title={HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule.},
  author={Helena W{\aa}llberg and Jonas Grafstr{\"o}m and Qing Cheng and Li Lu and Hanna-Stina Martinsson Ahlz{\'e}n and Erik Sam{\'e}n and J O Thorell and Katarina Johansson and Finn Dun{\aa}s and Maria H{\"a}gg Olofsson and Sharon Stone-Elander and Elias S. J. Arn{\'e}r and Stefan St{\aa}hl},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2012},
  volume={53 9},
  pages={1446-53}
}
UNLABELLED A rapid, reliable method for distinguishing tumors or metastases that overexpress human epidermal growth factor receptor 2 (HER2) from those that do not is highly desired for individualizing therapy and predicting prognoses. In vivo imaging methods are available but not yet in clinical practice; new methodologies improving speed, sensitivity, and… CONTINUE READING